LU85639A1 - Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang - Google Patents

Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang Download PDF

Info

Publication number
LU85639A1
LU85639A1 LU85639A LU85639A LU85639A1 LU 85639 A1 LU85639 A1 LU 85639A1 LU 85639 A LU85639 A LU 85639A LU 85639 A LU85639 A LU 85639A LU 85639 A1 LU85639 A1 LU 85639A1
Authority
LU
Luxembourg
Prior art keywords
weight
approximately
phosphatidyl
phosphatidyl serine
extract
Prior art date
Application number
LU85639A
Other languages
English (en)
French (fr)
Inventor
Aurelio Romeo
Francesco Della Valle
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of LU85639A1 publication Critical patent/LU85639A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Epoxy Resins (AREA)
  • Heat Treatment Of Steel (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
LU85639A 1983-11-17 1984-11-13 Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang LU85639A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4935583 1983-11-17
IT49355/83A IT1212900B (it) 1983-11-17 1983-11-17 Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna

Publications (1)

Publication Number Publication Date
LU85639A1 true LU85639A1 (fr) 1985-06-04

Family

ID=11270453

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85639A LU85639A1 (fr) 1983-11-17 1984-11-13 Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang

Country Status (25)

Country Link
US (1) US4595680A (da)
EP (1) EP0148045B1 (da)
JP (1) JPH0676334B2 (da)
KR (1) KR870001330B1 (da)
AT (1) ATE35415T1 (da)
AU (1) AU572228B2 (da)
BE (1) BE901074A (da)
CH (1) CH661734A5 (da)
DE (1) DE3472406D1 (da)
DK (1) DK168271B1 (da)
ES (1) ES8608528A1 (da)
FI (1) FI79946C (da)
FR (1) FR2555050B1 (da)
GR (1) GR80951B (da)
HU (1) HU193302B (da)
IE (1) IE58130B1 (da)
IL (1) IL73420A (da)
IN (1) IN162717B (da)
IT (1) IT1212900B (da)
LU (1) LU85639A1 (da)
MX (1) MX160792A (da)
NO (1) NO164275C (da)
NZ (1) NZ210091A (da)
PT (1) PT79510B (da)
ZA (1) ZA848776B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471776A1 (fr) * 1979-12-21 1981-06-26 Oreal Nouveaux agents cosmetiques a base de polymeres cationiques, compositions cosmetiques les contenant, et leur application
IT1213034B (it) * 1986-02-12 1989-12-07 Istituto Chemioterapico Di Lod Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
US5314695A (en) * 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent
FR2673512B1 (fr) * 1991-03-05 1993-08-20 Inst Rech Biolog Sa Nouvelles compositions dietetiques a base de lipides complexes phosphores et leur utilisation dans les troubles du sommeil.
IT1247165B (it) * 1991-03-15 1994-12-12 Fidia Spa Uso terapeutico della fosfatidilserina e derivati in patologie degenerative anche associate a disfunsioni immunitarie.
IT1248012B (it) * 1991-06-07 1995-01-05 Mediolanum Farmaceutici Spa Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.
IT1260149B (it) * 1992-04-17 1996-03-28 Fidia Spa Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
GB9621293D0 (en) * 1996-10-11 1996-11-27 Scotia Holdings Plc Formulations containing unsaturated fatty acids
CA2393595A1 (en) * 1999-12-10 2001-06-14 Gigi Chiu Lipid carrier compositions with protected surface reactive functions
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
CA2319928A1 (en) 2000-09-18 2002-03-18 Vasogen Ireland Limited Apoptosis-mimicking synthetic entities and use thereof in medical treatments
TWI281407B (en) * 2000-09-18 2007-05-21 Vasogen Ireland Ltd Apoptosis-mimicking synthetic entities and use thereof in medical treatment
US6676963B1 (en) * 2000-10-27 2004-01-13 Barnes-Jewish Hospital Ligand-targeted emulsions carrying bioactive agents
US20040234544A1 (en) * 2001-08-09 2004-11-25 Ralf Jager Formulation containing (lyso-)phosphatidylserine for the prevention and treatment of stress states in warm blooded animals
AU2003229693A1 (en) * 2002-04-19 2003-11-03 Biohurt Biograde Gmbh & Co. Kg Matrix comprising a bioactive component containing phospholipid
US6878532B1 (en) 2003-04-28 2005-04-12 Sioux Biochemical, Inc. Method of producing phosphatidylserine
CN1308334C (zh) * 2004-06-01 2007-04-04 山东师范大学 一种从动物脑提取磷脂酰丝氨酸的方法
IL182372A0 (en) * 2007-04-01 2008-01-20 Enzymotec Ltd Compositions containing phosphatidylserine in treating diabetes-associated conditions
ITMI20121784A1 (it) * 2012-10-22 2014-04-23 Velleja Res Srl Composizioni galattogeniche a base di fosfatidilserina
US20160317560A1 (en) * 2013-11-07 2016-11-03 The University Of North Carolina At Chapel Hill Particles containing phospholipids or bioactive fatty acids and uses thereof
IT202100032252A1 (it) * 2021-12-22 2023-06-22 Fidia Farm Spa Processo di estrazione e purificazione industriale di fosfolipidi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3156616A (en) * 1958-11-14 1964-11-10 Canada Majesty In Right Of Composition and method for correcting foods and blood conditions having clot promoting characteristics
US3436413A (en) * 1965-12-21 1969-04-01 Canada Packers Ltd Process for the isolation of phosphatidyl serine
FR5060M (da) * 1965-12-22 1967-05-08
US4078052A (en) * 1976-06-30 1978-03-07 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Large unilamellar vesicles (LUV) and method of preparing same
JPS55115824A (en) * 1979-02-28 1980-09-06 Nippon Shoji Kk Remedy for clouding of consciousness and sensomobile disorder

Also Published As

Publication number Publication date
FI844468A0 (fi) 1984-11-14
HU193302B (en) 1987-09-28
IT1212900B (it) 1989-11-30
NZ210091A (en) 1988-06-30
ES8608528A1 (es) 1986-07-16
HUT35957A (en) 1985-08-28
IN162717B (da) 1988-07-02
EP0148045B1 (en) 1988-06-29
PT79510B (en) 1986-09-08
JPS60132921A (ja) 1985-07-16
NO164275B (no) 1990-06-11
CH661734A5 (fr) 1987-08-14
US4595680A (en) 1986-06-17
FI79946B (fi) 1989-12-29
IE842785L (en) 1985-05-17
BE901074A (nl) 1985-05-17
AU3563084A (en) 1985-05-30
ZA848776B (en) 1986-06-25
GR80951B (en) 1984-12-18
DK168271B1 (da) 1994-03-07
AU572228B2 (en) 1988-05-05
PT79510A (en) 1984-12-01
KR870001330B1 (ko) 1987-07-18
NO164275C (no) 1990-09-19
IE58130B1 (en) 1993-07-14
MX160792A (es) 1990-05-17
JPH0676334B2 (ja) 1994-09-28
FI844468L (fi) 1985-05-18
ES537575A0 (es) 1986-07-16
IL73420A0 (en) 1985-02-28
EP0148045A1 (en) 1985-07-10
DE3472406D1 (en) 1988-08-04
FI79946C (fi) 1990-04-10
ATE35415T1 (de) 1988-07-15
NO844585L (no) 1985-05-20
KR850003504A (ko) 1985-06-20
DK524884A (da) 1985-05-18
FR2555050A1 (fr) 1985-05-24
IL73420A (en) 1988-06-30
DK524884D0 (da) 1984-11-02
FR2555050B1 (fr) 1986-12-26
IT8349355A0 (it) 1983-11-17

Similar Documents

Publication Publication Date Title
LU85639A1 (fr) Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang
Russell Pharmacology of animal venoms
KR100489371B1 (ko) 산화성스트레스로발생한심혈관계및신경계통질환의예방과치료에유용한l-카르니틴,이들의유도체및항산화제의용도
FR2482093A1 (fr) Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
US6051613A (en) Nitrogen monoxide production suppressor
FR2491475A1 (fr) Procede de preparation de sulfate de chondroitine et composition pharmaceutique contenant ce dernier
EP1656131B1 (fr) Utilisation de la betaine pour le traitement de la claudication intermittente
Curzon et al. Unesterified fatty acids and the binding of tryptophan in human plasma
EP3746057B1 (en) Dapansutrile for preventing or treating alzheimer's disease
Drenckhahn et al. Experimental myopathy induced by amphiphilic cationic compounds including several psychotropic drugs
FR2529081A1 (fr) Composition therapeutique a base d'acide 5-hydroxydecanoique ou d'un de ses derives pour le traitement des maladies cardiovasculaires
JP2022521119A (ja) 組織の灌流の増加における使用のためのイノシトールリン酸化合物
US5447720A (en) Composition and method for treatment of hemoglobinopathies
EP0149847A2 (en) Therapeutic and preventive agent containing dolichol
JP2001261556A (ja) 平滑筋異常収縮の抑制剤
FR2600892A1 (fr) Utilisation du fructose-1,6-diphosphate pour la preparation d'une composition pharmaceutique pour la protection contre la toxicite induite par l'administration d'anthracyclines et compositions correspondantes
BE882048A (fr) Agent carcinostatique et immunostimulant contenant un lysophospholipide et un phospholipide et procede pour le preparer
FR2630008A1 (fr) Poudre de vers de terre sechee utile comme medicament et procede pour sa preparation
CA1235659A (en) Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation
RU2520695C1 (ru) Комплекс биологически активных веществ для лечения и профилактики заболеваний сердечно-сосудистой системы
KR20180113658A (ko) 말굽버섯의 에틸아세테이트 추출물을 포함하는 혈관 이완용 조성물
RU2086238C1 (ru) N,n-дибензилглицин и его производные, обладающие способностью проникать через гематоэнцефалический барьер
WO1990009977A1 (fr) Complexe d'ion calcium avec au moins un acide insature, composition pharmaceutique l'incorporant
FR2555899A1 (fr) Composition pharmaceutique contenant au moins un derive d'acide glycyrrhetinique et au moins un derive de xanthine
JPH06172211A (ja) アルツハイマー病の予防、治療薬